These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7791158)

  • 1. Circulating interleukin 1 beta and soluble interleukin 2 receptor: evaluation as markers of disease activity in scleroderma.
    Patrick MR; Kirkham BW; Graham M; Harrision LC
    J Rheumatol; 1995 Apr; 22(4):654-8. PubMed ID: 7791158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxyfilline treatment does not influence the plasma levels of IL-2 and sIL-2R in limited scleroderma patients.
    Chibowska M; Krasowska D; Weglarz J
    Med Sci Monit; 2001; 7(2):282-8. PubMed ID: 11257736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
    Steen VD; Engel EE; Charley MR; Medsger TA
    J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.
    Clements PJ; Peter JB; Agopian MS; Telian NS; Furst DE
    J Rheumatol; 1990 Jul; 17(7):908-10. PubMed ID: 2213757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
    J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
    Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
    J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z; Zhang J; Zhang S; Li L
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
    Symons JA; Wood NC; Di Giovine FS; Duff GW
    J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.
    Wasik MA; Vonderheid EC; Bigler RD; Marti R; Lessin SR; Polansky M; Kadin ME
    Arch Dermatol; 1996 Jan; 132(1):42-7. PubMed ID: 8546482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis.
    van den Brink HR; van Wijk MJ; Geertzen RG; Bijlsma JW
    J Rheumatol; 1994 Mar; 21(3):430-4. PubMed ID: 7911833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
    J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
    J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Soluble receptors of cytokines in sera of patients with systemic sclerosis--clinical correlation].
    Lis AD; Brzezińska-Wcisło LA
    Wiad Lek; 2003; 56(11-12):532-6. PubMed ID: 15058159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.